SUTRO BIOPHARMA, INC. Research And Development Expense

Quick Answer

SUTRO BIOPHARMA, INC. reported Research And Development Expense of $166.42 million for the year ending 2025.

  • SUTRO BIOPHARMA, INC. showed a decrease of -34.0% in Research And Development Expense from 2024 to 2025.
  • This data is from SUTRO BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), SUTRO BIOPHARMA, INC.'s Research And Development Expense has grown by 282.1%.
  • Historical annual values: Fiscal year 2025: $166.42 million | Fiscal year 2024: $252.04 million | Fiscal year 2023: $180.43 million | Fiscal year 2022: $137.17 million | Fiscal year 2021: $104.40 million | Fiscal year 2020: $76.96 million | Fiscal year 2019: $65.61 million | Fiscal year 2018: $54.26 million | Fiscal year 2017: $54.64 million | Fiscal year 2016: $43.55 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: